BridgePort Financial Solutions’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$822K Sell
13,547
-2,474
-15% -$144K 0.23% 85
2025
Q4
$864K Buy
16,021
+11,143
+228% +$536K 0.23% 83
2025
Q3
$220K Buy
+4,878
New +$228K 0.06% 219
2025
Q2
Sell
-3,317
Closed -$202K 199
2025
Q1
$202K Buy
+3,317
New +$193K 0.09% 156

Other funds holding BMY

BridgePort Financial Solutions's BMY Position: Q1 2026 in Review

BridgePort Financial Solutions reduced its Bristol-Myers Squibb (BMY) stake by 15% in Q1 2026, selling an estimated $144K and leaving 13,547 shares worth $822K. The position accounts for 0.23% of the portfolio, ranked #85.

BridgePort Financial Solutions first reported a position in BMY in Q1 2025 and has held it in 4 quarters since. The position peaked at $864K in Q4 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • BridgePort Financial Solutions held 13,547 shares of Bristol-Myers Squibb worth $822K as of Q1 2026.
  • BridgePort Financial Solutions sold 2,474 Bristol-Myers Squibb shares in Q1 2026, an estimated $144K.
  • Bristol-Myers Squibb made up 0.23% of BridgePort Financial Solutions's portfolio in Q1 2026, its #85 holding.
  • BridgePort Financial Solutions first reported a position in Bristol-Myers Squibb in Q1 2025 and has held it in 4 quarters since.
  • BridgePort Financial Solutions's Bristol-Myers Squibb position peaked at $864K in Q4 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on BridgePort Financial Solutions's 13F filing for Q1 2026, filed 16 Apr 2026.